NCT00442689View on ClinicalTrials.gov

Metabolic Syndrome in PCOS: Precursors and Interventions

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Polycystic Ovary SyndromeMetabolic Syndrome
Interventions
DRUG

flutamide

250 mg twice daily

DRUG

ethinyl estradiol 35 mcg and drospirenone 3 mg

one active pill per day for three weeks and then 1 sugar pill per day for one week

OTHER

placebo

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Northwestern University

OTHER

NCT00442689 - Metabolic Syndrome in PCOS: Precursors and Interventions | Biotech Hunter | Biotech Hunter